Integrating quercetin with nano-based formulations presents a novel and promising approach for targeted skin cancer therapy. While preclinical results are encouraging, further experimental and clinical investigations are necessary to fully validate these findings and facilitate translation into clinical practice.
Khanyabzadeh et al. (2026) studied this question.